7th Circuit restores breach-of-contract case against Eli Lilly
The appellate court held that Teva plausibly alleged that Lilly breached the two companies’ 2018 settlement agreement, which stipulated that Lilly would not interfere with Teva getting approval for a generic version of Lilly’s osteoporosis drug, Forteo.